Previous Article | Next Article 
The Journal of Neuroscience, December 15, 2002, 22(24):10985-10995
Effectiveness of Estrogen Replacement in Restoration of Cognitive
Function after Long-Term Estrogen Withdrawal in Aging Rats
Alicja L.
Markowska and
Alena V.
Savonenko
Neuromnemonics Laboratory, Department of Psychology, Johns Hopkins
University, Baltimore, Maryland 21218
 |
ABSTRACT |
Recent studies suggest that some aspects of learning and memory may
be altered by a midlife loss of estrogen, indicating a potential causal
relationship between the deficiency of ovarian hormones and cognitive
aging. In this study, the effects of estrogen withdrawal and
replacement were tested in middle-aged Fischer-344 rats using different
memory tasks. Estrogen withdrawal accelerated the rate of cognitive
aging. A deficit first occurred 4 months after ovariectomy in working
memory, which was tested in a delayed-nonmatching-to-position task, and
progressed from long-delay to short-delay trials. Reference memory,
which was tested in a place discrimination task and a split-stem
T-maze, was not affected by aging or ovariectomy. The efficacy of
estrogen in ameliorating the cognitive deficit in old rats
depended on the type of treatment (acute vs chronic) and whether the
aging-related decline in a particular cognitive process was aggravated
by estrogen withdrawal. Chronic estrogen treatment (implants) was
effective in improving working memory only when primed with repeated
injections of estrogen, indicating that simulating the estrogen
fluctuations of the estrous cycle may be more effective than the widely
used mode of chronic pharmacological treatment. A challenge with
scopolamine revealed that ovariectomy-induced cognitive deterioration
coincided with a compromised cholinergic system. Importantly, the
estrogen treatment that had restored effectively the cognitive
abilities of old ovariectomized rats did not reduce their sensitivity
to scopolamine. Taking into consideration that estrogen was highly
effective against the amnestic action of scopolamine when tested in
young-adult rats, these data emphasize that mechanisms of the
protective effect of estrogen differ in young and old rats.
Key words:
ovariectomy; cholinergic system; scopolamine; working
memory; attention; body weight
 |
INTRODUCTION |
Recent studies suggest that some
aspects of learning and memory may be altered by the midlife loss of
estrogen (Sherwin, 1988
). These changes can be ameliorated by estrogen
replacement therapy (Ditkoff et al., 1991
; Sherwin, 1994
; Kimura,
1995
), indicating a potential causal relationship between the
deficiency of ovarian hormones and cognitive aging. In previous studies
conducted on animal models, estrogen replacement has been shown to
improve the performance of ovariectomized rats in radial mazes (Daniel et al., 1997
; Luine et al., 1998
; Fader et al., 1999
) and water mazes
(O'Neal et al., 1996
), in the operant alternation task (Dohanich et
al., 1994
; Fader et al., 1998
), and in the active avoidance task (Singh
et al., 1994
). However, because only two groups of rats (ovariectomized
and estrogen-replaced) generally have been used, it is impossible to
determine whether the superiority of the estrogen-replaced rats was
attributable to a cognition-enhancing effect of estrogen or to a
deleterious effect of estrogen deprivation in the ovariectomized rats.
If aging is considered as an intervening factor, the impact of these
effects is likely to change significantly.
Our previous studies have indicated that there is no cognitive deficit
immediately after ovariectomy, and that the deleterious effect on
cognition is delayed for a longer period of time in young females than
in older females (Markowska and Grinnell, 1999
). Therefore, aging
should be considered as a factor that increases the susceptibility of
cognitive function to the effects of estrogen withdrawal. Likewise, the
effect of estrogen replacement varies depending on the age of females
and the duration of treatment (Gibbs, 1998
, 2000b
; Gibbs and Aggarwal,
1998
).
The first goal of this study was to assess the effects of estrogen
withdrawal on the rate of cognitive aging in two groups of middle-aged
female rats: (1) the control group that had intact ovaries and
naturally decreasing estrogen levels during aging and (2) the
ovariectomized rats that had undergone aging along with a surgically
reduced level of estrogen. Middle age coincides with the onset of an
age-related loss of ovarian hormones; therefore, middle-aged female
rats may be an ideal model to test the effects of estrogen replacement
on memory during aging (Markowska, 1999b
).
When tested in young-adult rats, the duration and modes of estrogen
treatment have been shown to be critical factors in determining the
physiological (Gorzalka and Moe, 1994
; Reilly et al., 1996
), neuronal
(Gibbs, 1998
, 2000a
), and cognitive effects (Luine et al., 1998
) of
treatment. These factors also may modulate the effectiveness of
estrogen replacement on cognition during aging. Therefore, the second
goal of this study was to characterize the effectiveness of estrogen
replacement in middle-aged and old ovariectomized rats by using various
durations and two modes of estrogen administration: acute injections
and chronic implants. The acute mode of treatment was designed to
simulate a naturally occurring fluctuation in the estrogen level during
the estrus cycle (the injections were omitted every fourth day) and to
reduce the probability of side effects by using a phasic, but not
tonic, replacement. The chronic mode of treatment was used as a regimen
that models more closely the pharmacological replacement of estrogen.
The assessment of these two treatments is particularly important in
view of the recent findings from clinical trials in which daily
administration of drugs containing a pharmacological dose of estrogen
induced undesirable side effects in women (Grady et al., 2002
; Hulley at al., 2002
).
The third goal of this study was to evaluate the ability of estrogen to
enhance cholinergic function during aging. A muscarinic antagonist,
scopolamine (SCOP), was used before and after the estrogen treatment in
the old females to estimate the efficacy of estrogen in
counterbalancing the amnestic effects.
 |
MATERIALS AND METHODS |
Subjects
Thirteen-month-old Fischer-344 female rats (n = 30) were obtained from the colony at the National Institute of Aging.
The rats (three rats per cage) were housed on a 12 hr light/dark cycle. Food and water were provided ad libitum except for the
periods of behavioral testing in the appetitively motivated tasks, in which water deprivation was necessary to create appropriate motivation for the task (for details, see DNMP task). To avoid the estrogen-like effect of phytoestrogens, which are found in many laboratory animal diets (Thigpen et al., 1999
), the rats were fed a special diet without
phytoestrogen content (5K96C; Purina Test Diet, Richmond, IN).
Group treatment
After a 5 d acclimation period, rats were divided randomly
into two groups. One group (n = 20) received
ovariectomy (OVX), whereas the other group (n = 10) received sham surgery with skin and muscles cut but ovaries spared
(Sham). After the recovery period (3 d), each rat was handled for 5-10
min daily over 5 d.
The rats were tested repeatedly during seven testing periods (periods
1-7), starting 1 month after ovariectomy and continuing for the next 9 months (Fig. 1). Behavioral testing
included the delayed-nonmatching-to-position (DNMP) task, the
spontaneous alternation task, place and visual discrimination, straight
swim, and repeated acquisition in the water maze.

View larger version (43K):
[in this window]
[in a new window]
|
Figure 1.
Design of the experiment and group treatment.
Sham, Control rats with sham surgery in which ovaries
were spared. OVX, Ovariectomized rats. E,
Treatment with 17 -estradiol: i, acute, with
injections; m, chronic, with implants. Injections of
SCOP were applied during periods 4 and 5.
|
|
Six months after ovariectomy, during period 5, the OVX rats were
divided randomly into two subgroups. The first half of OVX rats
(OVX1 group) and Sham rats were injected
subcutaneously with 0.1 ml of sesame oil, whereas the second half of
OVX rats (OVX2) received subcutaneous injections
of estrogen (10 µg of 17
-estradiol dissolved in 0.1 ml of sesame
oil). Next, 5 d before period 6, OVX2 rats
were given estrogen implants. The OVX1 rats
received estrogen implants 5 d before period 7. Sham rats received
placebo implants. To control for neuroendocrine status, vaginal smears were obtained daily during 20 d in each of the seven testing
periods. Body weight was recorded twice weekly during the course of the experiment.
SCOP challenges
During period 4, both Sham and OVX rats received intraperitoneal
injections of saline (0.9% NaCl solution; Sigma, St. Louis, MO), SCOP
(0.05, 0.1, and 0.2 mg/kg in saline; Sigma), or methylscopolamine (0.2 mg/kg in saline; Sigma) 20 min before behavioral testing. Each drug and
dose was applied three times in a semirandom order with intertreatment
intervals of 3-4 d.
During period 5, SCOP was administered to Sham,
OVX1, and OVX2 rats twice;
in the OVX2 group, SCOP was administered after the second and the fourth set of estrogen injections. Because at that
time all rats were already 20 months of age, only the minimal dose of
SCOP (0.05 mg/kg) was used.
Ovariectomy
The rats were anesthetized with an intraperitoneal injection of
Nembutal (40 mg/kg; Abbott Labs, Abbott Park, IL). Fur on both sides of
the body was shaved from a hip to the lowest rib. Bilateral
ovariectomies were performed using an incision 1.5 cm inferior to the
palpated rib cage. Ovaries and surrounding fat tissue were removed; the
incision was closed by suturing the muscles and stapling the skin.
Antibiotic gel was applied on the wound, and the animal was placed on
paper towels in a temperature-controlled cage until awakening.
Vaginal cytology
To monitor the stages of estrus cyclicity, cell samples were
obtained by vaginal lavage, fixed, and stained in accordance with the
Wright-Giemsa method (Hema 3, Fisher Scientific, Houston, TX).
Next, the vaginal smears were investigated under the microscope and
diagnosed for estrus stage (i.e., estrus, diestrus, or proestrus). Estrus stage was defined by the predominance of cornified cells in the
vaginal lumen. The following period in which the cornified cells became
less numerous and leukocytes and nucleated cells were present was
defined as diestrus. Proestrus was defined as the time during which the
vaginal smear was characterized by the predominance of nucleated
epithelial cells (Feder, 1981
). The duration of the estrus cycle was
estimated as a number of days between consecutive estrus stages.
Estrogen treatments
The subcutaneous injections of estrogen contained 10 µg of
17
-estradiol (Sigma) dissolved in 0.1 ml of sesame oil (Sigma). The
dose of estrogen chosen in this study was shown to be effective in
inducing the structural synaptic changes in the hippocampus in
young rats (Woolley and McEwen, 1994
), and it partially restored levels
of choline acetyltransferase mRNA in the medial septum in old rats
(Gibbs and Aggarwal, 1998
). Each rat from group
OVX2 received multiple estrogen injections,
scheduled as shown in Figure 2.
17
-Estradiol injections for 3 consecutive days with no injection on
the fourth day constitute one treatment set. This schedule of estrogen
injections approximately models the natural drop in the level of
estrogen every fourth day of the estrus cycle. Injections were given
after behavioral training on days 1 and 2 and before the training on
day 3. Rats from the OVX2 group received four sets of estrogen injections with 12 d between set 2 and set 3. During this period, SCOP was tested twice (see SCOP challenges).

View larger version (18K):
[in this window]
[in a new window]
|
Figure 2.
The schedule of 17 -estradiol injections. One
set consisted of the three injections as shown in the figure.
Ovariectomized rats (group OVX2) received four sets
of injections.
|
|
Silastic tubing pellets (length, 5 mm; inner diameter, 1.47 mm), filled
for 3 mm with 17
-estradiol, were placed in saline solution
(0.9% NaCl) at 37°C for 24 hr before implantation. The pellet then
was implanted under the skin of the neck when the rat was anesthetized
with a gas anesthesia (a mixture of O2,
N2O2, and enflurane;
Ohmeda, Liberty Corner, NJ). Behavioral testing started 5 d after implantation.
Sampling estradiol concentration
Once per month, the rats were anesthetized with gas anesthesia
(see above), and a vein on the side of the tail was cut 5-6 cm up from
the tip. Using peristaltic motion, 1 ml of blood was collected into an
Eppendorf tube containing 0.1 ml of heparin. Plasma was collected by
spinning the tubes for 30 min at 4°C and then stored at -70°C
until ready for 125I-radioimmunoassay for
17
-estradiol (DSL-4800 kit; Diagnostic Systems, Webster, TX).
Behavioral testing
DNMP task
Rats were tested in a split-stem T-maze that has been described
previously (Hepler et al., 1985
; Markowska et al., 1990
). The
50-cm-long stem was divided into two halves by a partition. At the end
of the partition proximal to the arms, a black cloth curtain was placed
on both sides of the stem. A clear Plexiglas barrier placed behind one
curtain blocked access to the arms on that side of the stem. The
correct side of the stem was assigned randomly to rats but remained
constant for each rat throughout the experiment. Each arm of the maze
was 37 cm long and had a food cup 1 cm from the end. Chocolate milk was
used as reinforcement for choosing the correct arm. To prevent possible
orientation by the smell of the milk, several other cups filled with
milk were placed beneath the stem and arms. Background masking noise was provided by radio speakers. The location of extra maze cues and
speakers was held constant throughout the experiment.
The rats were deprived of water for 12 hr. Each daily session consisted
of 11 trials. For the first, forced trial, one arm of the maze was
blocked and the rat entered the opposite (baited) arm. After
reinforcement, the rat was placed back into the home cage for an
intertrial interval. During the next 10 trials, the rat was allowed to
choose arms freely, and reinforcement was placed on the side of the
maze that was not visited during the previous trial. After each trial,
the maze was cleaned with a dilute alcohol solution and dried with a
paper towel. During the first testing in DNMP (period 1), acquisition
training was conducted with a minimal intertrial delay (20-25 sec) and
continued up to the criteria of 85% correct choices over 2 consecutive
days. After the rat reached the criteria, longer intertrial delays were
introduced (1, 5, 15, or 30 min). Each delay was used for three
sessions and scheduled in a semirandom order. The number of correct
choices in the stem and arms and the maximum consecutive correct arm
choices in each session were measured.
Water maze tasks
Water maze apparatus. A large metal pool (180 cm in
diameter) filled with opaque water at 24 ± 2°C and a 10 cm
platform were used in place discrimination, repeated acquisition, and
visual discrimination tasks. A straight plastic alley (10 × 70 cm) was placed in the large pool and used during the straight swim test to estimate swimming ability. To prevent fatigue and changes in thermoregulation, the rat was removed from the pool and dried with a
towel after each trial. The tracking system (HVS Image Analysis VP-200;
HVS Image, Hampton, UK) acquired images from a camera mounted 1.4 m above the surface of the water. Eight 40 W bulbs, mounted in a
parallel configuration 1.2 m above the surface of the water,
provided lighting.
Straight swim test. This test, described in detail
previously (Markowska et al., 1993
), assessed the swimming ability of
the rat in the straight alley and was conducted for two sessions of five trials each. The latency and swim speed to reach the platform at
the end of the straight alley were recorded. The test was conducted 1 d before the place discrimination task.
Place discrimination task. This task has been described in
detail previously (Markowska et al., 1993
, 1998
). Each rat received 1 d of training with three sessions of five platform trials and one probe trial each and a random order of start positions. During the
platform trials, the platform was submerged but accessible to the rat,
whereas during the probe trials, the platform was collapsed at the
bottom of the tank for variable intervals (10-40 sec) to test the
subject's preference for the platform location. The collapsed platform
was then returned to its raised position at the end of the probe trial
to maintain the same response-reinforcement contingency as in the
platform trials (Markowska et al., 1993
). Latency [the time to reach
the platform from the start location (in seconds)], distance [the
path from the start location to the platform (in centimeters)], and
swim speed [the average speed during a trial (in centimeters per
second)] were measured during the platform trials. A lower score in
the platform measures (except for swim speed) indicates better
performance. In the probe trials, a percentage of time spent in the
correct quadrant was assessed. Higher scores in this index reflected
better performance. Location of the platform and a set of spatial cues
around the tank were changed between the testing periods. The test was
conducted during periods 1-3, 6, and 7 (see Fig. 1).
Repeated acquisition task. The training started on the day
after the place discrimination task and consisted of 1 d of
training with two sessions of nine trials each. During the first
session, the set of extra maze cues, as well as the location of
platform, was different from that on the previous place discrimination
task. During the second session, the platform was moved to the new
position, with the set of external cues remaining the same. Each
session consisted of eight platform trials and one probe trial. The
measures of platform and probe trials were the same as in the place
discrimination task. The task was conducted during periods 3, 6, and 7 (see Fig. 1).
Visual discrimination task. The tank was surrounded by a
black curtain to eliminate spatial cues, and rats were required to find
the platform based on its visible high-contrast extension sitting 0.5 cm above the surface of the water. The platform was moved to different
quadrants of the pool and at different distances from the walls for
every trial. The start position was changed randomly for each trial.
The measures of performance were the same as those for the platform
trials in the place discrimination task. The test (two sessions, six
trials each) was conducted at the conclusion of water maze training.
Spontaneous alternation in Y-maze
Each arm of the Y maze was 55 × 15 cm. The rat was placed
in one arm and allowed to move freely through the maze for a 5 min test
session. The sequence of arm entries was recorded. An
alternation was defined as the number of triads containing entries
into all three arms divided by the maximum possible alternations
(Stone et al., 1992
). After each trial, the maze was cleaned with a
dilute alcohol solution and dried with a paper towel.
Data analysis
The effect of ovariectomy during periods 1-4 was analyzed as a
between-subject main effect, with ANOVA conducted for each period
separately. The effects of ovariectomy and estrogen treatments during
periods 5-7 were analyzed by ANOVA with a main effect of groups (Sham,
OVX1, and OVX2) and were
followed by post hoc tests. The variables of performance in
different sessions or delays, or after different doses of SCOP
treatment, were used as repeated measures in a mixed-design ANOVA. The
performance in consecutive testing periods was analyzed in a
repeated-measures omnibus ANOVA. Post hoc Newman-Keuls
tests were applied to significant effects and interactions to estimate
the differences in the focused set of means. Some differences in the
levels of degrees of freedom reported in ANOVAs reflected the data
withdrawal of rats excluded from the study because of temporal or
permanent health problems (fur appearance, food consumption, cataracts,
etc.). When ANOVA yielded a significant effect for a set of variables
(for example, all variables of platform trials), F and
p values are presented as a range from minimum to maximum
(F(df) = minimum
maximum, minimum < p < maximum). Body weight was used as
a covariance to adjust the significance of between-group differences in
speed of swimming. Because the effect of covariance may be
overestimated if the group means for the measure used as a covariance
are significantly different, additional analysis was performed using
Pearson's correlation coefficient. The correlation between body weight
and speed of swimming was assessed separately in Sham and OVX rats to
avoid the potential confounding effect of between-group differences in
body weight. All statistical analyses were conducted using Statistica
8.0 (StatSoft, Tulsa, OK).
 |
RESULTS |
Changes in body weight in the course of estrogen withdrawal
and replacement
Beginning at 10 weeks after surgery, OVX rats were significantly
heavier than age-matched control rats
(F(1,27) = 4.12; p < 0.05) (Fig. 3). This difference was
observed during both food deprivation periods and food ad
libitum periods. The estrogen injections (group
OVX2, period 5) quickly abolished the effect of
ovariectomy on body weight. Following treatment with implants (period
6) further decreased body weight below the level of the Sham group
(F(1,11) = 12.32; p < 0.01). Estrogen implants also decreased body weight when applied in the
OVX1 group (period 7); therefore,
OVX1 rats were no longer different from Sham rats
(p > 0.8). Therefore, the gain in body weight
in OVX rats was reversed easily by both modes of estrogen treatment,
injections and implants, indicating that the mechanisms of regulating
of body weight by estrogen remained spared with aging.

View larger version (24K):
[in this window]
[in a new window]
|
Figure 3.
The dynamics of body weight in control (sham
surgery, open squares) and experimental [ovariectomized
OVX1 (gray circles) and
OVX2 (open triangles) ] groups of
Fischer-344 rats during periods 1-7 of behavioral testing. A decrease
in body weight during every period was attributable to food deprivation
during testing in the DNMP task. Note that OVX rats gained weight
compared with Sham rats, and this effect of ovariectomy was abolished
quickly by both types of estrogen treatment (injections and
implants).
|
|
Changes in estrous cycle and in plasma estrogen levels in the
course of estrogen withdrawal and replacement
At the beginning of the experiment, 13-month-old female rats
showed irregular cyclicity with a high variability of the cycle duration (range, 3-10 d). However, a majority of cycles (79%) contained a proestrus stage. In Sham rats, the number of cycles with
proestrus substantially decreased at the age of 15 months (36%) and
was not detectable at the age of 18-19 months. The estrus cycles of
20- to 22-month-old Sham rats contained the long periods of diestrus
(8-12 d), infrequently followed by the short estrous stages.
Ovariectomy in 13-month-old females resulted in cessation of estrus
cycle, and the vaginal smears of OVX rats were characterized by a
predominance of leukocytes (88% of slides). Estrogen treatment (injections and/or implants) administered 7-8 months after ovariectomy resulted in vaginal cytology with a prevalence of cornified cells (90%
of slides).
Because 13-month-old females at the beginning of the experiment already
showed irregular cyclicity, and because the probability of proestrus
stage decreased further with more advanced age, the plasma was
collected only during diestrus. The estrogen plasma level in the Sham
group was ~10 ± 1 pg/ml during diestrus and did not change
significantly across all ages tested (Fig.
4). Ovariectomized rats showed a very low
level of estrogen, close to the minimum detectable by the assay used.
Both types of estrogen treatments, injections and implants (Fig. 4),
created estrogen concentration in plasma similar to physiological
levels during proestrus (Feder, 1981
; Gans et al., 1995
; Matsuda et
al., 2002
).

View larger version (23K):
[in this window]
[in a new window]
|
Figure 4.
Plasma level of estrogen in Sham (diestrus) and
OVX rats during behavioral testing (periods 1-7). The gray
bar indicates the level of estrogen 1 hr after injection of 10 µg of 17 -estradiol (OVX2 group, open
triangles). The plasma estrogen concentration tested 5 d
after implantation of pellets with 17 -estradiol was similar in both
OVX1 (period 6, open squares) and
OVX2 (period 7) groups. The level of estrogen slightly
decreased when tested 1 month after implantation (OVX1
group, period 7). Filled circles, Sham.
|
|
DNMP task
Ovariectomy increases the rate of aging-associated decline in
working memory
Ovariectomy did not affect the rate of acquisition in the DNMP
task. The number of sessions it took to reach the criteria of 85% of
correct arm choices in 2 consecutive days was 11.5 ± 1.6 and
11.7 ± 1.1 for the Sham and OVX groups, respectively. The
percentage of correct alternations of the arms increased significantly during the first 6 d of training
(F(5,140) = 8.12; p < 0.0001) and was not different between groups
(F(1,28) = 1.57; p < 0.22). The acquisition of correct choices in the stem of the T-maze
(reference memory) was also similar in Sham and OVX rats
(F(1,28) = 0.60; p < 0.44).
The accuracy of correct choices in the stem of the T-maze as a measure
of reference memory remained very high in the course of
aging (range, 90-100%; effect of testing periods;
p > 0.6) and was not different among Sham, OVX, and
estrogen-treated rats (p values > 0.7). There
were no group differences in retention of correct stem choices between
consecutive periods of testing (p values > 0.3).
The number of correct arm choices as a measure of working memory
decreased with aging. The omnibus ANOVA of choice accuracy in
short-delay trials (intertrial interval, 30 sec) revealed a significant
effect of period of testing (F(6,102) = 4.35; p < 0.001) and group
(F(2,17) = 6.10; p < 0.01). However, there were no significant differences between OVX and
Sham rats until 7 months after ovariectomy (group × period
interaction: F(12,102) = 1.98; p < 0.01). The choice accuracy of Sham rats gradually
declined after 19 months of age followed by a significant decrease at
22 months (post hoc test; p < 0.02)
(Fig. 5). The OVX rats showed a
significant age-related deterioration in working memory at 20 months of
age (post hoc test; p < 0.01), i.e.,
2 months earlier than Sham rats (Fig. 5).

View larger version (20K):
[in this window]
[in a new window]
|
Figure 5.
Aging-related changes in working memory tested in
the DNMP task. Each point represents the average percentage of correct
arm choices per group. Only sessions with regular, short-delay trials
and without SCOP treatment are shown. The dashed line
for the OVX2 group (open triangles)
indicates the age-related decline before the estrogen treatment. The
caret indicates the onset of the age-related decline in
the appropriate group as a result of a post hoc test
(p < 0.05). The asterisk
indicates a significant difference from the OVX1 group
(open circles) during the period (simple main-effect
ANOVA; p < 0.05). Open squares,
Sham.
|
|
When the demands on working memory were increased by the introduction
of longer intertrial delays (1-30 min), ovariectomized rats showed a
deficit in performance 4 months after ovariectomy, much earlier than
that in regular, short-delay trials (Fig.
6). The introduction of 1 and 5 min
delays 1 month after surgery (period 1) decreased the accuracy of arm
choices (effect of delay: F(2,56) = 19.48; p < 0.0001) in both Sham and OVX groups (Fig.
6A). Importantly, the accuracy of choice after the 5 min delay was close to a chance level, yielding no baseline for using
longer delays. Repeated testing decreased the sensitivity of
performance to delays (periods 1 and 2) (effect of retesting:
F(1,28) = 5.75; p < 0.03), which allowed the inclusion of 15 and 30 min delays during
period 3. The most challenging 30 min delay resulted in significant
differences between OVX and Sham groups (simple main effect:
F(1,27) = 4.83; p < 0.05) (Fig. 6C). Even more robust between-groups
differentiation was revealed in the variable of maximum consecutive
correct choices (Fig. 6F). OVX rats showed
significantly lower values of maximum consecutive correct choices in 5, 15, and 30 min delay trials (simple main effect; p
values < 0.05). It is important to note that the between-group
differences in this variable were revealed not only in the
longest-delay trials (30 min), where the total number of correct
choices was significantly lower in OVX rats, but also in trials where
no deficit occurred in the number of correct choices.

View larger version (37K):
[in this window]
[in a new window]
|
Figure 6.
Delay sensitivity of working memory in Sham
(open bars) and OVX (shaded bars) rats.
A-C represent the average percentage of correct arm
choices in trials with different delays. D-F represent
the maximum of consecutive correct choices. Asterisks
indicate significant effects of ovariectomy as a result of a simple
main-effect ANOVA (p < 0.05).
|
|
The data showed that the onset of ovariectomy-induced impairment in
working memory was first revealed in the trials with long delays and
high demands on working memory (4 months after ovariectomy, or period
3) and was followed by an additional decline in regular, short-delay
trials with lower demand on working memory (7 months after ovariectomy,
or period 5).
Ovariectomy increases cognitive sensitivity to SCOP in
aging rats
To estimate the effect of compromised cholinergic functioning on
T-maze alternation, both ovariectomized and control rats were injected
with SCOP. Different doses of SCOP (0.05, 0.1, and 0.2 mg/kg) were
administered systemically during period 4 of behavioral testing, when
the performance of OVX rats was not different from Sham rats in
regular, short-delay trials. Ovariectomized 19-month-old rats were more
sensitive to the effect of SCOP than age-matched control rats. In
contrast to Sham rats, OVX rats already had shown a significant decline
in choice accuracy after the lowest dose of SCOP (effect of dose:
F(3,42) = 9.39; p < 0.0001) (Fig. 7). Sham rats decreased
their choice accuracy after an increasing dose of SCOP, but this
decline did not reach significance (p > 0.07).
Moreover, the decline in choice accuracy induced by SCOP treatment
remained in OVX rats for at least 3 d, resulting in significant
differences between OVX and Sham rats in sessions without SCOP
injections (F(1,18) = 5.29;
p < 0.05).

View larger version (23K):
[in this window]
[in a new window]
|
Figure 7.
Effect of systemic SCOP (Sc)
administration on the accuracy of correct arm choices in OVX
(gray circles) and Sham (open
squares) groups (19-month-old rats, 6 months after
ovariectomy). The inset shows the effect of the lowest
dose of SCOP tested 1 month later. Note that OVX rats that received
estrogen treatment (group OVX2) were still more
sensitive to SCOP than Sham rats. Single and
double asterisks indicate a significant SCOP-induced
decline as a result of a post hoc test applied to the
significant effect of dose in the OVX group
(p < 0.01 or 0.001, respectively). A
decline in the performance of Sham rats did not reach significance
(p > 0.07). The pound sign
indicates a significant effect of SCOP as a result of a one-way,
repeated-measures ANOVA (p < 0.05).
|
|
However, when treatment with estrogen improved the choice accuracy in
OVX rats (period 5), the lowest dose of SCOP abolished the effect of
estrogen (Fig. 7). SCOP was administered after the second and fourth
sets of estrogen injections. However, in both cases the
estrogen-injected OVX2 rats significantly
decreased the accuracy of choices
(F(1,7) = 6.92; p < 0.05) and were not different from OVX1 rats, with
a performance close to a chance level.
Efficacy of different modes of estrogen treatment in ameliorating
the cognitive deficit
After OVX rats showed a significant age-related decline in working
memory in regular, short-delay probe trials (Fig. 5, period 5),
one-half of ovariectomized rats (OVX2) received
subcutaneous injections of 17
-estradiol (10 µg dissolved in 0.1 ml
of sesame oil), whereas the rest of the rats
(OVX1) received subcutaneous injections of
vehicle (sesame oil). 17
-Estradiol injections for 3 consecutive days
constitute one set of treatment (i.e., set 1, set 2, etc.) (Fig. 2).
The averages of choice accuracy on days 2 and 3 (after injections) are
shown in Figure 8A.
There was no effect of estrogen on choice accuracy during the first set
of injections. The ovariectomized rats that received a first set of
estrogen injections
(OVX2+Ei) were less
accurate than control rats and were not different from other
ovariectomized rats without injections (effect of group:
F(2,17) = 4.33; p < 0.03). The second set of estrogen injections led to a mild improvement
that was followed by more robust changes during the 6 d without
injections. During this period, the estrogen-injected rats
(OVX2+Ei) were not
different from Sham rats, whereas the choice accuracy of
OVX1 rats without injection was significantly
lower compared with Sham rats (effect of group:
F(2,17) = 4.69; p < 0.03). The protective effect of estrogen injections developed gradually
and was most robust after the third
(F(2,17) = 3.67; p < 0.05) and fourth (F(2,17) = 5.73;
p < 0.01) set of injections. In both cases, the
significant effect of group was revealed because of the differences
between Sham and OVX1 rats without estrogen
injections.

View larger version (45K):
[in this window]
[in a new window]
|
Figure 8.
Effect of 17 -estradiol injections
(A) and implants (B) on
ovariectomy-induced deterioration in working memory. The accuracy of
correct arm choices in control (Sham) rats is shown as 100%.
A, Ovariectomized rats that received repeated injections
of estrogen (group OVX2+Einjections, gray
bars) improved their performance to a level similar to that of
control rats. The performance of ovariectomized rats that did not
receive estrogen replacement (OVX1, striped
bars) deteriorating further during the testing (period 5). The
asterisks indicate a significant difference from control
rats (p < 0.05). B, The
treatment with estrogen implants was more effective in improving the
performance of ovariectomized rats if treatment was preceded by
estrogen injections (group OVX2, gray
bars). The asterisk shows a significant increase
in choice accuracy as an effect of estrogen implants; the
arrow indicates a significant difference between
OVX1 (striped bars) and OVX2
groups in choice accuracy between 5 and 9 d after implantation
(p < 0.05). The triangle
indicates the higher performance of the OVX2 group compared
with the OVX1 after a longer period of estrogen treatment;
however, because the exact duration of the treatment was different in
the OVX1 and OVX2 groups, the difference was
not statistically determined.
|
|
During period 6, the OVX2 rats, which previously
received injections of estrogen, were implanted with pellets containing
17
-estradiol (OVX2+Em)
(Fig. 1). Five days later, testing showed that rats with estrogen
implants improved their performance compared with that before
implantation, during period 5 (simple main effect: F(1,7) = 15.75; p < 0.01). Moreover, the
OVX2+Em group performed better than the two other groups
(F(2,17) = 6.75; p < 0.01) (Fig. 8B). The improved choice accuracy was
stable and did not change significantly when rats were tested 1 month
later (period 7).
During period 7, the remainder of the ovariectomized rats received the
estrogen implants (group
OVX1+Em) (Fig. 1). Testing, which started 5 d after implantation, showed that, in contrast to
the OVX2 group that received both types of
estrogen treatment, the OVX1 group did not
improve choice accuracy after implantation of estrogen pellets
(p > 0.8) (Fig. 8B).
Furthermore, the OVX1+Em rats were significantly less accurate than
OVX2+Em rats after the same
short-term period of implantation (5-9 d) (effect of group:
F(1,13) = 12.03; p < 0.005) (Fig. 8B). Two weeks after implantation, the
OVX1+Em group slightly
improved their level of performance so that they were not different
from the Sham group. However, considering that at the age of 22 months
Sham rats already have shown a significant age-related decline (Fig.
5), the absence of difference between Sham and
OVX1+Em rats could be
attributable to the decline in control rats rather than to the effects
of estrogen replacement.
Spontaneous alternation in the Y-maze task
No differences were observed between Sham and OVX groups,
indicating that the ovariectomized rats showed deficits in working memory compared with control rats only when higher demands on working
memory were imposed, such as in the DNMP task.
Place discrimination in the water maze
No differences in spatial reference memory were observed between
control and OVX rats up to 9 months after surgery (Fig.
9A,B). The only
ovariectomy-induced difference in place discrimination performance was
observed for the variable of speed of swimming (Fig. 9C).
Starting 1 month after surgery, OVX rats swam significantly slower than
Sham rats (F(1,28) = 4.69-33.32 for
periods 1-7; 0.001 < p < 0.05). Estrogen
replacement did not reduce existing differences in swim speed, although
it brought back the body weight to the level of Sham rats.

View larger version (15K):
[in this window]
[in a new window]
|
Figure 9.
Performance of Sham and ovariectomized
(groups OVX1 and OVX2) rats in platform
(A) and probe (B) trials of
the place discrimination task. The dotted line in
B indicates chance level. The average speed of swimming
during platform trials is shown in C. For treatments of
OVX1 (gray circles) and
OVX2 (gray triangles) groups, see
Figure 1. Pound signs indicate a significant improvement
in place discrimination attributable to retesting compared with
period 1 (post hoc test applied to a significant
effect of period; p < 0.05).
Asterisks indicate a significant difference between
control and ovariectomized rats (OVX1 and
OVX2) as a result of a post hoc test
applied to a significant effect of group (p < 0.05). Open squares, Sham.
|
|
In the range of ages tested (13-22 months), no effect of aging was
revealed. Moreover, repeated testing improved the performance of old
rats in both platform (Fig. 9A) and probe (Fig.
9B) trials compared with middle-aged naive rats (effect of
period for different variables:
F(4,68) = 12.34-45.98; p
values < 0.01).
Although the place discrimination task is one of the most sensitive
tasks to detect the effect of aging on reference memory (Gage et
al., 1984
; Fischer et al., 1992
; Markowska et al., 1994
; Lindner, 1997
; Foster et al., 2001
), repeated testing of the same animal at different time points during aging ameliorates this aging-related deficit (Beatty et al., 1985
; Algeri et al., 1991
; Dellu
et al., 1997
; Markowska, 1999a
; Markowska and Savonenko, 2002
).
Considering that in the present study rats were tested repeatedly, the
absence of an aging-related decline in place discrimination suggests
that the protective effect of experience was sufficient enough to
reduce the effect of aging in both Sham and ovariectomized rats.
Repeated acquisition in the water maze
The interaction of the effects of aging and repeated testing in
the repeated acquisition task was more complex than in the place
discrimination task. At 17 months of age, the rats were tested in this
task for the first time (Fig. 10,
period 3). Sham and ovariectomized rats learned the new positions of
the platform and did not differ with regard to the time spent in the
correct quadrant (Fig. 10A,B).

View larger version (32K):
[in this window]
[in a new window]
|
Figure 10.
The preference for the quadrants
with and without the platform tested after the first
(A) and second (B) session
in the repeated acquisition task. Each bar indicates the
time spent in the quadrant with the most recent platform location
(mean ± SEM). The time spent in the quadrant with a previous
platform location is indicated as a marker (mean).
Thick lines indicate a range of preferences for two
other nonplatform quadrants. The previous correct quadrant for session
1 was a quadrant with a platform location used in the place
discrimination task. See Figure 1 for treatments for the
OVX1 and OVX2 groups. Significant
between-groups differences in the preference for the correct quadrant
were revealed only in the first session, in which a change in the
platform location coincided with partial changes in spatial cues.
Asterisks indicate a significant difference from Sham
rats as a result of a post hoc test applied to a
significant effect of group (p < 0.05).
|
|
When tested at 21 months of age, preference to the correct quadrant
significantly declined in both Sham and OVX1 rats
(session 1) (effect of period: F(1,16) = 9.32; p < 0.01) (Fig. 10A).
Importantly, the memory of old rats for the new platform location was
not accurate, because preference was distributed between two quadrants
(Fig. 10A, period 6). Importantly, the second
quadrant with a high preference was one of the adjacent quadrants but
not the one with the old platform location. This indicates that poor
memory for the platform location after the first session of the
repeated acquisition task was not a result of interference with
memories for the old platform location but, instead, of difficulties in
learning the new position of the platform.
In the first session the change in the platform location was
accompanied by the alteration in spatial cues. Notably, because only
some of the spatial cues were changed, whereas others such as the
geometry of the room and the location of light sources were the same,
the rat's navigation could have been affected by the interference
between the new and the old set of spatial cues. This additional
complexity of the first session, when learning of the new platform
location required the complex differentiation between interfering sets
of spatial cues, was the most challenging stage of learning for
21-month-old rats.
Estrogen replacement in the OVX2 rats that
received both types of treatment (injection and implants, period 6)
increased the preference of the correct quadrant at the end of the
first session (effect of group:
F(2,32) = 77.52; p < 0.0001) (Fig. 10A). However, 21-month-old
OVX2+Ei+Em
rats, which had been equally successful in the preference of the
correct quadrant as 17-month-old rats, showed as high a preference of
one of the adjacent quadrants as was observed in 21-month-old Sham and
OVX1 rats. This indicates that the estrogen
treatment ameliorated the aging-related decline but did not change
markedly the strategy used by old rats to cope with a poor memory of
the new platform location.
During the second session of period 6 (Fig. 10B),
when a set of spatial cues remained the same and only the platform
location was changed, Sham and OVX1 rats learned
the new platform location more successfully than during the first
session and were no longer different from estrogen-treated
OVX2+Ei+Em
rats (session × group interaction:
F(4,32) = 3.84; p < 0.02). Compared with period 3, sham and ovariectomized rats improved
their performance (session 2) (effect of period:
F(1,16) = 12.42; p < 0.01) because of the effect of retesting and/or because of a different
strategy than that used by 17-month-old naive rats (see different
ranges of time spent in nonplatform quadrants in Fig.
10B, periods 3-6).
When tested 1 month later (period 7), all three groups
improved performance during the first session (effect of
period: F(1, 16) = 21.39;
p < 0.001) (Fig. 10A). With
additional training, 22-month-old Sham rats were able to learn the new
position of the platform at a level similar to 17-month-old rats. These
data are consistent with our previous results, which showed a
protective effect of training against an aging-related decline in the
repeated acquisition task in Fischer male rats (Markowska and
Savonenko, 2002
). The OVX2 rats that received
both types of estrogen treatment outperformed Sham rats (effect of
group: F(2,16) = 4.88;
p < 0.03). The OVX1 rats that
received estrogen implants without priming with estrogen injections
showed a significantly higher preference for the correct quadrant than
Sham rats (post hoc; p < 0.05), but
they were still less accurate than the OVX2 group
(p > 0.1). Similar to the previous periods of
testing, there were no differences during the second session
(session × group interaction:
F(4,32) = 2.86; p < 0.05). Surprisingly, the preference for the correct quadrant during the second session was not improved as in period 6. The high preference for
the correct quadrant during the first session (Fig.
10A, period 7) could have proactive effects,
impairing learning on the second session. However, this view is
difficult to credit, because in all groups of rats the time spent in
the previous correct quadrant during the second session was at the
chance level (Fig. 10B).
An alternative explanation of the performance differences between
periods 6 and 7 during the second session is that the strategy applied
by the rats in period 7 was different and presumably less effective
when the platform was changed repeatedly. During period 6, the high
preference for the correct quadrant (group
OVX2+Ei+Em in session 1 and all groups in session 2) coincided with a low visiting
(below the chance level) of the two other quadrants (the previous
correct quadrant was one of those quadrants). During period 7, only one
of the nonplatform quadrants was rejected, and two others (including
the previous correct quadrant) were visited at the chance level. This
switch in the rejection of the previous correct quadrant resulted in a
strategy that would be less and less effective with consecutive changes
in the platform location. As was shown in male rats, an ability to
reject the previous platform location significantly declines between 18 and 24 months of age (Markowska and Savonenko, 2002
). The difference in
the strategies observed in females between period 6 (21 months of age)
and period 7 (22 months of age) is likely also to be age-related.
Importantly, 22-month-old OVX2 rats that
previously received both types of estrogen treatment were able to
reject the previous platform location during the first session.
However, these rats switched to the strategy inherent to age-matched
controls when the platform location was changed again (session 2).
These data suggest that estrogen treatment may partially ameliorate the
aging-related changes in strategy rather than cause the differences in
strategies between old Sham and estrogen-treated OVX rats (Fig.
10A, period 7).
There were no between-group differences in latency and distance in the
platform trials in any of the testing periods. All groups shortened
distance and latency to find the platform during every period of
testing (effect of trials; p values < 0.01). The pattern of differences in swim speed was similar to that in the place
discrimination task.
Compared with the DNMP task, the aging-related decline in the repeated
acquisition task was less robust and was ameliorated by additional
training. A relatively lower demand on working memory in the repeated
acquisition task, in which the information changes between sets of
trials but not in each trial as in the DNMP task, could contribute to
this difference. Importantly, unlike the DNMP task, the age-related
deficit in the repeated acquisition task was not aggravated by
ovariectomy. In this case, the chronic estrogen treatment (implants)
was sufficient to ameliorate the aging-related changes.
Straight swim and visual discrimination in the water maze
A decrease in swim speed in the straight alley was detected in OVX
rats 4 months after surgery (period 3)
(F(1,27) = 8.56; p < 0.01). It is noteworthy that an ovariectomy-induced alteration in swim
speed was detected earlier in the place discrimination task, in which
an uncertainty of the situation is higher and consequently more
stressful for rats than in the straight alley. This suggests that
ovariectomy in middle-aged rats affected an emotional rather than a
motivational component of escaping from the water.
The other factor that could affect the speed of swimming is body weight
(Markowska, 1999a
; Markowska and Savonenko, 2002
). However, an increase
in body weight was already observed 2 months earlier (period 2) without
any significant impact on the speed of swimming. When body weight was
used as covariance, ANCOVA still yielded a significant effect of groups
in swim speed (F(1,26) = 5.26;
p < 0.03). Moreover, there was no significant
correlation between body weight and swim speed in either Sham
(r =
0.34; p > 0.35) or
ovariectomized groups (r =
0.10; p > 0.65).
The estrogen treatment (injections and implants;
OVX2 group; period 6) did not significantly
affect the swim speed compared with the nontreated ovariectomized rats
(p > 0.2). Furthermore, at 22 months of age
(period 7), when both groups of ovariectomized rats
(OVX1 and OVX2) received
estrogen replacement for >1 month, the body weight of the
OVX1+Em and
OVX2+Em rats was similar to or lower than the body weight of Sham rats (Fig. 3). However, the speed
of swimming of estrogen-treated rats was still significantly lower than
that of Sham rats (effect of group; p < 0.01).
There was no significant effect of ovariectomy or estrogen treatment on
performance in the visual discrimination task (distance to visible
platform; effect of group; p > 0.3).
 |
DISCUSSION |
This study demonstrated that the rate of age-related decline in
various cognitive functions was differentially affected by estrogen
withdrawal. Accelerated aging in working memory function, but not in
reference memory, was the most prominent consequence of estrogen
withdrawal in middle-aged females. The cognitive impairment after
ovariectomy was gradual (taking several months to be detected), initially occurred in tasks that placed more demands on working memory,
and then was detected progressively in the easier tasks. The efficacy
of estrogen in reversing the deficit in working memory as tested in the
DNMP task was increased by priming the chronic estrogen administration
(implants) with repeated injections, which more closely mimicked the
natural estrogen cyclicity. The age-related deficit in working memory,
as tested in the repeated acquisition task, was not accelerated further
by estrogen withdrawal and was more responsive to both modes of
estrogen replacement (injections and implants). Finally, a challenge
with the muscarinic antagonist SCOP during estrogen withdrawal revealed
that the ovariectomy-induced cognitive deterioration coincided with a
compromised cholinergic system. Nonetheless, the estrogen treatment
that had effectively restored working memory in old ovariectomized rats
failed to block the amnestic action of SCOP.
These results support the hypothesis that the sensitivity of a
particular cognitive process to estrogen withdrawal parallels its
sensitivity to aging. In a longitudinal design of this experiment, where the same rats are tested repeatedly, the DNMP task was the first,
from a battery of cognitive tasks, to show a detrimental effect of
ovariectomy. This task was also the most sensitive to the effect of
aging. The cognitive sensitivity to both aging and estrogen withdrawal
may depend on a working memory component in the task, with the highest
demand in the DNMP task and the lowest demand in the place
discrimination task. The effects of estrogen withdrawal in aging rats
seemed to mirror the effects of estrogen replacement in young animals,
in which estrogen facilitates performance as working memory loads
increase (Bimonte and Denenberg, 1999
).
Importantly, the measure of maximum consecutive correct choices in the
DNMP task was the most sensitive to ovariectomy-induced changes in
cognition. In contrast to regular measures of working memory (the
percentage of correct choices), this measure was significantly affected
in OVX rats in a wide range of delays (5-30 min). This indicated that
the ovariectomy-induced alteration in the maximum of consecutive
correct choices was not attributable to the lower level of correct
choices in OVX rats. The maximum number of consecutive correct choices
reflects the extent to which correct performance can be maintained over
a prolonged period of time. Although the DNMP task was not designed
specifically to test attention span, this variable can be interpreted
as a measure of sustained attention. The assessment of attention may be
conducted not only by using a particular behavioral task but also by
measuring the commonality engaged in different types of procedures
(Bushnell, 1998
). That OVX rats failed to maintain the appropriate
level of vigilance in a set of consecutive trials implied that there
was a possible deficit in attention. This view is consistent with
results on aged ovariectomized monkeys, which showed a significant
decline in attention 2 months after ovariectomy (Tinkler and Voytko,
2000
). Considering the data of this study, the deficit in attention
might be an initial effect of long-term estrogen withdrawal that is followed by a deficit in working memory.
An alternative explanation of ovariectomy-induced differences in the
consecutive correct choices is a possible effect of estrogen withdrawal
on strategies during performance in the DNMP task. One may suggest that
ovariectomy could affect the balance between place/nonplace strategies
that is shown to be sensitive to estrogen manipulations (Korol and
Kolo, 2002
). However, in this case the measure of consecutive correct
choices most likely would be affected together with the total number of
correct choices. Notably, when assessed in the other spatial task
(repeated acquisition in the water maze), neither ovariectomy nor
estrogen replacement significantly affected strategies to solve the
task. However, consistent with previous studies (Barnes et al., 1980
;
Kobayashi et al., 1988
), we observed changes in learning strategies as
the animals aged. A shift in strategies observed between different
periods of testing in the repeated acquisition task was most likely
attributable to the age-related inability to reject the previous
platform location (Markowska and Savonenko, 2002
). Estrogen treatment
partially ameliorated rather than directly caused this aging-related
shift in strategies between old Sham and estrogen-treated OVX rats.
At the age at which memory impairment was detected only in OVX rats but
not in Sham rats (17-20 months), the functions of ovaries in Sham rats
already had been compromised substantially by aging, as indicated by
the termination of the proestrus stage. Thus, the differences in
working memory between old OVX and Sham rats were not caused by the
actual drop in estrogen at the time of testing but rather by
consequences of estrogen withdrawal at a younger age, when ovaries were
more functional. The persistence of the effect of estrogen well beyond
the period of exposure has also been documented in the working memory
of young rats (Daniel et al., 1997
). In Sham rats with a natural
aging-related decline in neuroendocrine functions, the onset of the
cognitive deficit was also delayed by 3-4 months after a cessation of
the proestrus stage. Considering that the surgical estrogen withdrawal
resulted in a cognitive deficit 4 months after surgery, the same
delayed principle of the effect of natural estrogen withdrawal has been observed in normally aging subjects.
The central cholinergic system is a good example of a system in which
the interaction of the effects of the aging processes (Biegon et al.,
1986
; Fischer et al., 1992
; Olton and Markowska, 1992
; Olton et al.,
1992
; Markowska et al., 1995
) and estrogen withdrawal (Fader et al.,
1999
; Gibbs, 1999
; Miller et al., 1999
) may affect cognition. In the
present study, the ovariectomized rats with an accelerated rate of
cognitive aging were more sensitive than the Sham rats to a
SCOP-induced impairment in working memory. They were also impaired in
the ability to restore normal cognitive functions after SCOP treatment.
More importantly, the ability of the estrogen treatment to restore
working memory in old rats was not paralleled by appropriate changes in
sensitivity to the amnestic action of SCOP. The minimal dose of SCOP,
which was sufficient to impair the performance of ovariectomized rats
in the DNMP task, was still effective after the estrogen treatment.
These data clearly indicate that the estrogen treatment that had been
effective in restoring the cognitive abilities of old rats did not
cause changes in cholinergic function to counter the effects of SCOP.
Our results are consistent with a previous study (Gibbs, 2000b
),
showing that estrogen failed to reduce the SCOP-induced deficits in the
delayed-matching-to-position task when tested in 22- to 25-month-old
female rats. Because estrogen prevents the impairment in working memory
after SCOP if administered in younger rats (Fader et al., 1999
; Gibbs,
1999
), these data clearly indicate that the mechanisms underlying the
protective effect of estrogen replacement may be different when applied
in young and old subjects. This view is supported by data showing an
aging-related decline in the ability of estrogen to stimulate cholinergic (Singer et al., 1998
) and neurotrophin (Jezierski and
Sohrabji, 2001
) functions. Considering that estrogen has multipotent effects in a variety of neuromediator systems (McEwen et al., 1997
),
and that the aging processes can differentially affect various systems,
the effects of estrogen treatment at old age are more likely to rely on
mechanisms that were relatively spared during aging. Therefore, the
strategy for treatment of cognitive consequences of neuroendocrine
imbalance in aged females should also consider other neuromediator
systems, which may have been relatively spared during aging.
The question of whether the deficit in working memory induced by
long-term estrogen withdrawal can be ameliorated or reversed by
estrogen treatment if applied at advanced ages has very important clinical implications. The enhancing effect of estrogen on working memory was documented repeatedly in young rats (O'Neal et al., 1996
;
Daniel et al., 1997
; Bimonte and Denenberg, 1999
). In the present
study, the chronic estrogen treatment (implants) did not improve
cognitive abilities in old ovariectomized rats when a cognitive deficit
already had been detected in the DNMP task. These results are in
accordance with clinical data showing a limited role of estrogen
replacement therapy in cognitive enhancement in women already diagnosed
with Alzheimer's disease (Henderson et al., 2000
; Mulnard et al.,
2000
; Wang et al., 2000
). Importantly, the same estrogen treatment was
still effective in old rats when a cognitive process was relatively
spared during aging and was not aggravated by ovariectomy, as was shown
in the repeated acquisition task.
However, when treatment with implants was primed with estrogen
injections, the working memory of old ovariectomized rats was improved
significantly, indicating that cognitive sensitivity to estrogen
treatment at advanced age could be restored. This also indicated that a
low effectiveness of estrogen implants in old rats was not caused by an
insufficient level of estrogen but, rather, by a lack of readiness of
the organism to respond to such treatment. The mechanisms of priming
with estrogen injections might be related to the cyclical nature of the
replacement as well as to the high levels (although brief) of estrogen
in the first minutes after injections. Although additional studies are needed to differentiate between these possibilities, the present data
clearly indicate that the efficacy of estrogen treatment on the
cognition of old rats is highly successful with a phasic but not tonic
replacement paradigm. In view of the negative results of the recently
halted clinical trial in which estrogen (together with progesterone)
was administered daily (Fletcher and Colditz, 2002
), the results of the
present study strongly advocate a phasic (cyclic) administration of
estrogen. This paradigm appears to be highly beneficial for cognitive
improvement and may produce fewer side effects than continuous daily administration.
 |
FOOTNOTES |
Received May 20, 2002; revised Oct. 3, 2002; accepted Oct. 3, 2002.
This study was supported by National Institute on Aging Grant AG15947
to A.L.M. We thank Y. Aguirre, J. L. Morton, K. Phelan, and D. Waters for their assistance with behavioral testing and J. L. Morton and L. Sims for editorial assistance.
Correspondence should be addressed to Alicja L. Markowska, National
Institute on Aging, Gateway Building, Suite 2C-212, Bethesda, MD 20892. E-mail: markowsa{at}nia.nih.gov.
 |
REFERENCES |
-
Algeri S,
Biagini L,
Manfridi A,
Pitsikas N
(1991)
Age-related ability of rats kept on a life-long hypocaloric diet in a spatial memory test. Longitudinal observations.
Neurobiol Aging
12:277-282[Medline].
-
Barnes CA,
Nadel L,
Honig WK
(1980)
Spatial memory deficit in senescent rats.
Can J Psychol
34:29-39[ISI][Medline].
-
Beatty WW,
Bierley RA,
Boyd JG
(1985)
Preservation of accurate spatial memory in aged rats.
Neurobiol Aging
6:219-225[ISI][Medline].
-
Biegon A,
Greenberger V,
Segal M
(1986)
Quantitative histochemistry of brain acetylcholinesterase and learning rate in the aged rat.
Neurobiol Aging
7:215-217[ISI][Medline].
-
Bimonte HA,
Denenberg VH
(1999)
Estradiol facilitates performance as working memory load increases.
Psychoneuroendocrinology
24:161-173[Medline].
-
Bushnell PJ
(1998)
Behavioral approaches to the assessment of attention in animals.
Psychopharmacology (Berl)
138:231-259[Medline].
-
Daniel JM,
Fader AJ,
Spencer AL,
Dohanich GP
(1997)
Estrogen enhances performance of female rats during acquisition of a radial arm maze.
Horm Behav
32:217-225[Medline].
-
Dellu F,
Mayo W,
Vallee M,
Le Moal M,
Simon H
(1997)
Facilitation of cognitive performance in aged rats by past experience depends on the type of information processing involved: a combined cross-sectional and longitudinal study.
Neurobiol Learn Mem
67:121-128[ISI][Medline].
-
Ditkoff EC,
Crary WG,
Cristo M,
Lobo RA
(1991)
Estrogen improves psychological function in asymptomatic postmenopausal women.
Obstet Gynecol
78:991-995[Abstract/Free Full Text].
-
Dohanich GP,
Fader AJ,
Javorsky DJ
(1994)
Estrogen and estrogen-progesterone treatments counteract the effect of scopolamine on reinforced T-maze alternation in female rats.
Behav Neurosci
108:988-992[ISI][Medline].
-
Fader AJ,
Hendricson AW,
Dohanich GP
(1998)
Estrogen improves performance of reinforced T-maze alternation and prevents the amnestic effects of scopolamine administered systemically or intrahippocampally.
Neurobiol Learn Mem
69:225-240[ISI][Medline].
-
Fader AJ,
Johnson PE,
Dohanich GP
(1999)
Estrogen improves working but not reference memory and prevents amnestic effects of scopolamine of a radial-arm maze.
Pharmacol Biochem Behav
62:711-717[ISI][Medline].
-
Feder HH
(1981)
Estrous cyclicity in mammals.
In: Neuroendocrinology of reproduction: physiology and behavior (Adler NT,
ed), pp 179-345. New York: Plenum.
-